GTC
Ghost Tree Capital’s Protagonist Therapeutics PTGX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-75,000
| Closed | -$2.17M | – | 72 |
|
|
2024
Q1 | $2.17M | Sell |
75,000
-50,000
| -40% | -$1.45M | 0.6% | 48 |
|
|
2023
Q4 | $2.87M | Sell |
125,000
-275,000
| -69% | -$6.31M | 0.94% | 27 |
|
|
2023
Q3 | $6.67M | Buy |
400,000
+175,000
| +78% | +$2.92M | 2.19% | 10 |
|
|
2023
Q2 | $6.21M | Hold |
225,000
| – | – | 2.05% | 18 |
|
|
2023
Q1 | $5.18M | Buy |
+225,000
| New | +$5.18M | 1.53% | 25 |
|
|
2020
Q2 | – | Sell |
-227,827
| Closed | -$1.61M | – | 45 |
|
|
2020
Q1 | $1.61M | Sell |
227,827
-47,173
| -17% | -$333K | 0.43% | 37 |
|
|
2019
Q4 | $1.94M | Buy |
275,000
+25,000
| +10% | +$176K | 0.37% | 40 |
|
|
2019
Q3 | $3M | Buy |
250,000
+50,000
| +25% | +$601K | 0.77% | 31 |
|
|
2019
Q2 | $2.42M | Sell |
200,000
-500,000
| -71% | -$6.06M | 0.5% | 35 |
|
|
2019
Q1 | $8.8M | Buy |
+700,000
| New | +$8.8M | 2.3% | 16 |
|